Bottom line
PHSYX vs SCHLX: the short answer
PHSYX (Putnam Global Health Care Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 70% by weight.
PHSYX is cheaper at 0.79% vs 1.06% — a difference of $27 a year per $10,000 invested.
Updated Nov 19, 2026
PHSYX vs SCHLX side by side
| PHSYX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.79% | 1.06% |
| Annual cost per $10k | $79 | $106 |
| 10-yr cost on $10k (prospectus) | $978 | $1,294 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +1.5% | — |
| 5-yr return (annualized) | +8.1% | — |
| 10-yr return (annualized) | +7.8% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $1.5B | $231.8M |
| Number of holdings | 115 | 65 |
| Portfolio turnover | 67% | 2% |
| Returns as of | Dec 31, 2024 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of PHSYX's top 25 holdings also appear in SCHLX's top 25.
| Holding | PHSYX | SCHLX |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.85% |
| Johnson & Johnson | 8.46% | 6.19% |
| UnitedHealth Group, Inc. | 6.93% | 5.73% |
| AbbVie, Inc. | 6.05% | 4.90% |
| Merck & Co., Inc. | 4.88% | 4.85% |
| AstraZeneca plc | 4.67% | 3.80% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.46% |
| Intuitive Surgical, Inc. | 4.04% | 2.69% |
| Roche Holding AG | 2.79% | 1.24% |
| Gilead Sciences, Inc. | 2.63% | 2.78% |
| McKesson Corp. | 2.14% | 2.05% |
| Cardinal Health, Inc. | 2.12% | 1.34% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.45% |
| Boston Scientific Corp. | 1.80% | 2.10% |
| Bristol-Myers Squibb Co. | 1.75% | 1.50% |
Source: SEC Form N-PORT
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between PHSYX and SCHLX?
PHSYX (Putnam Global Health Care Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 70% by weight. PHSYX is cheaper at 0.79% vs 1.06% — a difference of $27 a year per $10,000 invested.
Which is cheaper, PHSYX or SCHLX?
PHSYX has the lower expense ratio (0.79%).
Should I own both PHSYX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.